These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 19484236)
1. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics. Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236 [TBL] [Abstract][Full Text] [Related]
2. 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics. Shi J; Kim YS; Chakraborty S; Jia B; Wang F; Liu S Bioconjug Chem; 2009 Aug; 20(8):1559-68. PubMed ID: 19603780 [TBL] [Abstract][Full Text] [Related]
3. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525 [TBL] [Abstract][Full Text] [Related]
4. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. Shi J; Kim YS; Zhai S; Liu Z; Chen X; Liu S Bioconjug Chem; 2009 Apr; 20(4):750-9. PubMed ID: 19320477 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties. Zhou Y; Kim YS; Lu X; Liu S Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387 [TBL] [Abstract][Full Text] [Related]
6. Comparison of biological properties of Zhao ZQ; Yang Y; Fang W; Liu S Nucl Med Biol; 2016 Nov; 43(11):661-669. PubMed ID: 27556955 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent. Chakraborty S; Shi J; Kim YS; Zhou Y; Jia B; Wang F; Liu S Bioconjug Chem; 2010 May; 21(5):969-78. PubMed ID: 20387808 [TBL] [Abstract][Full Text] [Related]
8. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides. Yang Y; Ji S; Liu S Bioconjug Chem; 2014 Sep; 25(9):1720-9. PubMed ID: 25144854 [TBL] [Abstract][Full Text] [Related]
9. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [TBL] [Abstract][Full Text] [Related]
10. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. Jia B; Shi J; Yang Z; Xu B; Liu Z; Zhao H; Liu S; Wang F Bioconjug Chem; 2006; 17(4):1069-76. PubMed ID: 16848417 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules. Ji S; Zhou Y; Shao G; Liu S Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129 [TBL] [Abstract][Full Text] [Related]
13. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166 [TBL] [Abstract][Full Text] [Related]
14. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging. Ji S; Czerwinski A; Zhou Y; Shao G; Valenzuela F; Sowiński P; Chauhan S; Pennington M; Liu S Mol Pharm; 2013 Sep; 10(9):3304-14. PubMed ID: 23875883 [TBL] [Abstract][Full Text] [Related]
15. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins. Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent. Zhang X; Chen X Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200 [TBL] [Abstract][Full Text] [Related]
17. Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides. Xu D; Zhao ZQ; Chen ST; Yang Y; Fang W; Liu S Nucl Med Biol; 2017 May; 48():1-8. PubMed ID: 28157625 [TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression. Zhou Y; Kim YS; Chakraborty S; Shi J; Gao H; Liu S Mol Imaging; 2011 Oct; 10(5):386-97. PubMed ID: 21521559 [TBL] [Abstract][Full Text] [Related]
19. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers. Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508 [TBL] [Abstract][Full Text] [Related]
20. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]